LOS ANGELES – Anne Wellington has been named managing director of the Cedars-Sinai Accelerator, which provides mentoring and financial support for early-stage health care companies as part of a 90-day program with the goal of bringing health-tech innovations to the marketplace. Based in the Cedars-Sinai Innovation Space across the street from the medical center, the accelerator is in the process of selecting its fourth class, which will begin in July. Wellington served as entrepreneur-in-residence for the third class, whose 10 companies graduated in November. She was previously chief product officer and a founding team member at health care analytics company Stanson Health, and was part of Cedars-Sinai’s electronic medical record go-live team in 2011. “As more health systems follow Cedars-Sinai’s lead in fostering innovation through accelerators, we will be growing to expand our leadership role in this space,” said Darren Dworkin, senior vice president and CIO at Cedars-Sinai, in a statement. “Anne will be working to ensure we continue to attract top-tier companies, the best talent and expand our ability to work with the new amazing technologies.”
LOS ANGELES – Ten health technology companies that completed the fall 2017 session of the Cedars-Sinai Accelerator Powered by Techstars have sealed new contracts and partnerships to bring their technologies to patient care.
The companies, chosen from more than 500 applicants to participate in the accelerator, worked for three months under the mentorship of Cedars-Sinai staff and leadership. The goal was to rapidly develop innovations aimed at solving existing healthcare problems and bring new ideas to the field. Company leaders presented their innovations to investors, mentors and leaders in December.
Most of the companies now have pilot projects underway with Cedars-Sinai, and others have secured commercial contracts with other health systems and companies.
“We can never underestimate that passion, which can be married with innovation to create new products to bring changes to health care,” said Dr. Richard Riggs, vice president and chief medical informatics officer at Cedars-Sinai, in a statement.
The companies are:
- Aiva – A voice-powered device that allows hospital patients to send requests to their caregivers, which will then route them to the correct department.
- CancerAid – A mobile app for cancer patients that provides individualized cancer therapy information and resources.
- CareScriptions by Seremedi – A mobile patient-care solution that helps equip home caregivers with tools and education.
- ChoiceMap – A system that helps patients understand treatment options and helps care teams tailor clinical decisions to each person’s needs.
- Gyant – A mobile app that uses artificial intelligence to help doctors diagnose, prescribe and recommend treatment options.
- Invio – A content management system that replaces the need for paper and regulatory binders in clinical trials.
- Lumeon – A digital health company with a care pathway orchestration platform.
- NarrativeDX – A patient experience platform with an artificial intelligence comment-processing platform that analyzes, diagnoses and pinpoints patients’ experiences and provides actionable insights.
- Sway Health – An app that provides digital preventive counseling.
- HemoLink by Tasso – A virtually painless blood-collection device that allows patients to draw their own blood samples for lab testing.
In addition to three months of personalized guidance, each company received $120,000 in seed money.
BOSTON – MassChallenge has chosen 32 digital health startups to participate in the startup accelerator’s digital health program, PULSE@MassChallenge for 2018. The new cohort will pair two champions from the areas of health care institutions, systems and payers with each startup to help them achieve funding rounds, pilot studies or other milestones. Participants receive free co-working space and an opportunity to apply for $50,000 in need-based startups, as well as the chance to compete for a share of $200,000 in no-equity cash. The PULSE program is geared to later stage companies that are ready to scale, have raised no more than $5 million and generate under $5 million in revenue. The goal of the program is to connect selected startups with strategic relationships, resources, mentoring, and community access needed to create an impact in digital health. “What you get is a clinically valuable technology that is also highly implementable,” said Nick Dougherty, program director for PULSE@MassChallenge, in a statement.
LONDON – Biopharmaceutical company Merck Sharp & Dohme and the accelerator Wayra UK have kicked off the third Velocity Health program to award up to $90,000 to two digital health startups using artificial intelligence and machine learning to support disease and illness prevention. Velocity Health was set up in 2015 to invest in digital innovation in healthcare to address the challenges outlined in the National Health Service’s Five Year Forward View. Previous programs focused on prevention in health care with an emphasis on diabetes prevention and cancer prevention. “Velocity Health 2018 aims to build on the achievements of the previous two years of Velocity Health and work with start-ups that truly complement the future of healthcare delivery,” said Dr. Junaid Bajwa, director of health care services at MSD, in a statement. “The NHS has made digital excellence the cornerstone of its future model and we must embrace this if we are to have a healthcare system fit for the 21st Century.”
SAN FRANCISCO & ANTWERP, Belgium – Wearable health startup Byteflies was selected to join the Google Launchpad Studio program to generate medical insights from raw sensor data. Google Launchpad Studio vets all technical and business plans for its startup candidates then brings them together with Google products and research teams in a six-month program. “We are excited to work with Byteflies,” said Malika Cantor, global lead at Google Launchpad Studio, in a statement. “They share our vision of applying machine learning to enable new applications in the healthcare industry.” Byteflies’ Sensor Dot is a modular wearable that uses machine learning to measure any vital sign, anywhere, anytime. “Two key components are needed to establish the importance of wearables in healthcare: high quality vital sign data and medical insights gleaned from those vital signs,” said Hans Danneels, CEO and co-founder of Byteflies. “Our versatile and modular Byteflies Sensor Dots take care of the first—with Google Launchpad, we can achieve the latter by working with the best machine learning experts in the world.”
CAESAREA, Israel and EINDHOVEN, Netherlands – Digital diabetes company DarioHealth Corp. has joined the HighTechXL accelerator with a goal of bringing personalized health care management to diabetes and pre-diabetes patients around the world. “We believe the industry is transforming from a device-driven industry to a personalized managed care, data and clinical outcome driven industry,” said Erez Raphael, chairman and CEO of DarioHealth, in a statement. “We are looking forward to collaborate with the accelerator team and find new ways to accelerate our growth.” Backed by an alliance of corporations and regional organizations, the HighTechXL Acceleration program is a three-month program designed to accelerate startups to their next stage of development, including to help them gain broader customer traction and secure development partnerships. DarioHealth develops cloud-based diabetes platforms that include a native mobile solution helping patients to manage diabetes-related information and a platform that facilitates coaching. The all-in-one Dario Blood Glucose Monitoring System is capable of sharing real-time results with healthcare professionals via the personalized AI-driven application.
‘What we can do together is phenomenal’
LOS ANGELES – Cedars-Sinai recently signed an agreement with a startup company that was part of its accelerator program.
The three-year agreement with health data software startup Noteworth will give the hospital’s physicians new ways to monitor patients at home.
“What we can do together is phenomenal,” said Joan August, vice president of service line operations at Cedars-Sinai.
With the Noteworth system, a physician can order patient generated health data from a patient’s electronic medical record. Once the data, such as vital signs, medication adherence and activity, are selected, Noteworth delivers appropriate digital health devices to the patient’s home, and provides support and training. Once the patient starts taking readings with the FDA-approved devices, secure data is sent back to the EMR in actionable, clinically relevant reports and customizable notifications.
August said that the ability to collect real-time data is one of the most important parts of the Noteworth system.
“It immediately sends that information to providers and that’s better help to them in terms of patient surveillance,” she said.
Cedars-Sinai is using the Noteworth system with cardiac patients to treat hypertension and congestive heart failure, as well as diabetes patients and high-risk mothers. They’re looking to use it for patients with chronic diseases in the future.
The Cedars-Sinai Accelerator invests $120,000 in each company and provides the chance to work side-by-side with physicians and patients who might use the product, as well as financing leaders, IT experts, reimbursement experts and other mentors, all while developing their technology.
“Rarely do developers get the chance to actually work this way,” said August. “All the pieces are together and we get all of those resources for them.”